Editor's note: FDA issued an updated safety communication regarding the recall on September 29, 2023.
On April 12, 2023, the U.S. Food and Drug Administration (FDA) issued a safety communication to healthcare providers, institutions, and consumers recommending that they do not use certain surgical N95 respirators manufactured by Owens and Minor Halyard and that they use certain surgical masks and pediatric face masks from Owens and Minor Halyard with caution. The recommendation comes after the masks failed fluid resistance performance tests.
FDA reported that laboratory test results show that certain models of Owens and Minor Halyard surgical N95 respirators, surgical masks, procedure masks, and pediatric face masks do not meet quality and performance expectations and may not provide fluid barrier protection. As of April 12, 2023, the manufacturer has not issued a voluntary recall, but it is conducting additional testing analysis. FDA said it is working with the manufacturer to evaluate those results.
Surgical N95 Respirators
The Owens and Minor Halyard surgical N95 respirators from the safety notice that should not be used include:
Device Name |
Model Number |
Fluidshield surgical N95 respirator mask, orange (regular), level 3 |
46727 |
Fluidshield surgical N95 respirator mask, orange (small), level 3 |
46827 |
FDA recommended that healthcare providers, institutions, and consumers:
- Check their supply of surgical N95 respirators for any of the affected models.
- Stop using the affected models.
- Do not purchase models from the listed surgical N95 respirators.
- Stay alert for updates and recommendations from FDA or the manufacturer.
- Report any issues with the quality or performance of Owens and Minor Halyard respirators or masks to FDA.
Surgical, Procedure, and Pediatric Face Masks
The Owens and Minor Halyard masks included in the safety notice that should not be used as fluid barrier protection are:
Manufacturer Device Name |
Model Number |
Surgical Masks |
|
Halyard surgical mask |
6000 |
Fluidshield level 3 fog-free surgical mask, wrap-around visor, orange |
28804 |
Fluidshield level 2 expanded chamber surgical mask with soft lining, blue and white |
39123 |
High-filtration surgical mask, silver |
47625 |
The Lite One surgical mask, blue |
48100 |
Halyard classic surgical mask, blue, pleated with ties |
48201 |
Halyard duckbill surgical mask, blue |
48220 |
Halyard Health (HYH) surgical mask, teddy bears |
48296 |
HYH surgical mask |
48390 |
Fog-free surgical mask, blue |
49214 |
Halyard anti-fog surgical mask, green |
49215 |
Halyard duckbill, fog-free surgical mask, blue |
49216 |
Procedure Masks |
|
Halyard procedure mask |
6001 |
Fluidshield level 1 procedure mask, lavender |
25868 |
Fluidshield level 1 procedure mask, blue |
25869 |
Fluidshield level 3 fog-free procedure mask, orange |
28797 |
Halyard level 1 procedure mask, yellow |
48388 |
Procedure mask, tissue blue |
47080 |
The Lite One procedure mask, blue |
62356 |
HYH procedure mask |
62363 |
Pediatric Face Masks |
|
Child face mask, white with Disney characters |
47127 |
FDA recommended that healthcare providers, institutions, and consumers:
- Check their supplies of surgical, procedure, and pediatric face masks for any of the affected models.
- Stop using the affected masks as fluid barrier protection against splashes, sprays, or splatters.
- Do not make new purchases of the affected models of surgical, procedure, and pediatric face masks.
- Stay alert for updates and recommendations from FDA or the manufacturer.
- Report any issues with the quality or performance of Owens and Minor Halyard masks or respirators to FDA.
FDA said that it is committed to ensuring that Owens and Minor Halyard surgical N95 respirators and face masks are appropriate for their approved use and provide the approved level of protection. FDA is conducting ongoing evaluation for Owens and Minor Halyard respirators and mask samples and working with international regulatory authorities. Stay tuned for more updates if significant new information becomes available.
Healthcare professionals and consumers should report any adverse reactions or quality problems they experienced using the product to MedWatch, FDA’s Safety Information and Adverse Event Reporting Program.